Maria Thomsen

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study

Tormod Kyrre Guren, Maria Thomsen, Elin H. Kure et al. · British Journal of Cancer · 2017 · 83 citations · Full text

Medicine, Oncology, Pharmacology +17

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

Maria Thomsen, Christian Kersten, Halfdan Sørbye et al. · Oncotarget · 2016 · 80 citations · Full text

Medicine, Immunology, Oncology +17

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome

Maria Thomsen, Eva Skovlund, Halfdan Sørbye et al. · British Journal of Cancer · 2018 · 68 citations · Full text

Medicine, Oncology, Pathology +17

AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin

Janne B Kjersem, Maria Thomsen, Tormod Kyrre Guren et al. · The Pharmacogenomics Journal · 2015 · 26 citations

Medicine, Molecular Medicine, Oncology +12

Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status

Maria Thomsen, Marianne G. Guren, Eva Skovlund et al. · European Journal of Cancer · 2017 · 21 citations

Medicine, Health Sciences, Oncology +15